AIM ImmunoTech Stock (AMEX: AIM) stock price, news, charts, stock research, profile.
Open | $0.500 |
Close | $0.420 |
Volume / Avg. | 169.268K / 231.140K |
Day Range | 0.400 - 0.500 |
52 Wk Range | 0.320 - 0.749 |
Market Cap | $21.316M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | AMEX |
RSI | 38 |
Short Interest | 0.99% |
Days to Cover | 1.3 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of AIM ImmunoTech (AMEX: AIM) through any online brokerage.
Other companies in AIM ImmunoTech’s space includes: NKGen Biotech (NASDAQ:NKGN), CERo Therapeutics Hldgs (NASDAQ:CERO), Serina Therapeutics (AMEX:SER), T2 Biosystems (NASDAQ:TTOO) and Addex Therapeutics (NASDAQ:ADXN).
The latest price target for AIM ImmunoTech (AMEX: AIM) was reported by Maxim Group on Thursday, October 10, 2019. The analyst firm set a price target for 0.00 expecting AIM to fall to within 12 months (a possible NaN% downside). 0 analyst firms have reported ratings in the last year.
The stock price for AIM ImmunoTech (AMEX: AIM) is $ last updated .
There are no upcoming dividends for AIM ImmunoTech.
AIM ImmunoTech’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for AIM ImmunoTech.
AIM ImmunoTech is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.